Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology

Mostrar otras versiones (1)

Despite many promising results obtained in previous preclinical studies, the clinical development of encapsulated cell technology (ECT) for the delivery of therapeutic proteins from macrocapsules is still limited, mainly due to the lack of an allogeneic cell line compatible with therapeutic applicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lathuiliere, Aurelien, Vernet, Remi, Charrier, Emily, Urwyler, Muriel, Von Rohr, Olivier, Belkouch, Marie-Claude, Saingier, Valentin, Bouvarel, Thomas, Guillarme, Davy, Engel, Adrien, Salmon, Patrick, Laumonier, Thomas, Grogg, Julien, Mach, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418741/
https://www.ncbi.nlm.nih.gov/pubmed/36092361
http://dx.doi.org/10.1016/j.omtm.2022.07.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418741/
https://www.ncbi.nlm.nih.gov/pubmed/36092361
http://dx.doi.org/10.1016/j.omtm.2022.07.017

Ejemplares similares